GLP-1 Market
LLY $1157.08 ▼ -2.3% NVO $37.91 ▼ -1.0% PFE $28.52 ▼ -0.7% VKTX $32.60 ▲ +2.5% KLRA $11.42 ▲ +3.9% GPCR $31.27 ▼ -4.3% RHHBY $51.91 ▼ -0.7%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Thiazolidinedione

Company
Chong Kun Dang Pharmaceutical
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
20 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

20 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 1, 2026

Find a Clinical Trial Near Me

See recruiting studies for Thiazolidinedione and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02969798

    Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

    Not yet reported The University of Texas Health Science Center at San Antonio 700 participants Est. completion 2027-07 1 site
    Type 2 diabetesPrediabetes
    View official trial listing →
  • Recruiting NCT NCT03109288

    Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 250 participants Est. completion 2029-01-01 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Recruiting NCT NCT04501406

    Low-Dose Pioglitazone in Patients With NASH (AIM 2)

    Not yet reported University of Florida 166 participants Est. completion 2027-08-31 1 site
    Type 2 diabetesMASH
    View official trial listing →
  • Recruiting NCT NCT05305287

    Quantifying Hepatic Mitochondrial Fluxes in Humans

    Not yet reported The University of Texas Health Science Center at San Antonio 60 participants Est. completion 2027-03-31 2 sites
    Type 2 diabetes Other conditions: Non-Alcoholic Fatty Liver Disease, Mitochondrial Metabolism Disorders
    View official trial listing →
  • Recruiting NCT NCT05501483

    Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes

    Not yet reported Karolinska Institutet 60 participants Est. completion 2032-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT05663515

    A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

    AstraZeneca 24000 participants Est. completion 2026-10-01 8 sites
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Recruiting NCT NCT05753657

    A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.

    Not yet reported Rambam Health Care Campus 30 participants Est. completion 2027-12-31 1 site
    Other conditions: Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug Induced
    View official trial listing →
  • Recruiting NCT NCT05838287

    Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants

    Not yet reported The University of Texas Health Science Center at San Antonio 78 participants Est. completion 2030-01 1 site
    Type 2 diabetesHeart failure
    View official trial listing →
  • Recruiting NCT NCT06246799

    Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

    Not yet reported The University of Texas Health Science Center at San Antonio 256 participants Est. completion 2029-06-30 2 sites
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT06336798

    Bioenergetic Effect of Pioglitazone in CLD-PH

    Not yet reported Emory University 20 participants Est. completion 2028-02 1 site
    Other conditions: Pulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases
    View official trial listing →
  • Recruiting NCT NCT06446531

    Prevention of Progression of Prediabetes, Obesity and CV Risk

    Not yet reported The University of Texas Health Science Center at San Antonio 64 participants Est. completion 2027-07 1 site
    PrediabetesCardiovascular disease Other conditions: Weight, Body
    View official trial listing →
  • Recruiting NCT NCT06528405

    The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease

    Not yet reported National Taiwan University Hospital 264 participants Est. completion 2027-12 1 site
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Recruiting NCT NCT06627322

    A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)

    Not yet reported Kyu Chang Won 5950 participants Est. completion 2029-09-30 2 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT06657209

    Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

    Not yet reported Stanford University 104 participants Est. completion 2027-12-15 2 sites
    Type 2 diabetes Other conditions: Diabetes, Pre Diabetes
    View official trial listing →
  • Recruiting NCT NCT06838286

    Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes

    Chong Kun Dang Pharmaceutical 10000 participants Est. completion 2029-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT06989723

    Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes

    Not yet reported Seoul National University Bundang Hospital 120 participants Est. completion 2027-06-30 1 site
    Type 2 diabetes Other conditions: Fatty Liver
    View official trial listing →
  • Recruiting NCT NCT07056699

    SGLT2i, Pioglitazone, and Ketone Production in T1D

    Not yet reported The University of Texas Health Science Center at San Antonio 24 participants Est. completion 2027-06-30 1 site
    Other conditions: Type1diabetes
    View official trial listing →
  • Recruiting NCT NCT07083388

    A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)

    Not yet reported Boryung Pharmaceutical Co., Ltd 52 participants Est. completion 2026-07-03 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT07117630

    An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy

    Not yet reported Fudan University 60 participants Est. completion 2027-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07462065

    Effect Clomiphene vs Clomiphene Along With Pioglitazone on Ovarian Stimulation Rate

    Not yet reported PAEC General Hospital, Islamabad 62 participants Est. completion 2026-06-01 1 site
    Other conditions: Infertility Treatment, Pregnancy Rates
    View official trial listing →
  • Completed NCT NCT00000620

    Action to Control Cardiovascular Risk in Diabetes (ACCORD)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 10251 participants Est. completion 2012-12 7 sites
    Cardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00004180

    Rosiglitazone in Treating Patients With Liposarcoma

    Not yet reported Dana-Farber Cancer Institute 32 participants Est. completion 2015-05 1 site
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00006305

    Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes

    Not yet reported University of Pittsburgh 2368 participants Est. completion 2009-03
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Insulin Resistance, Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent
    View official trial listing →
  • Completed NCT NCT00013598

    Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30 participants Est. completion 2004-03 1 site
    MASH Other conditions: Fatty Liver
    View official trial listing →
  • Completed NCT NCT00015626

    A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)

    Not yet reported National Center for Research Resources (NCRR) 300 participants 1 site
    Other conditions: Insulin Resistance, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00015691

    Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 105 participants 34 sites
    Other conditions: HIV Infections, Lipodystrophy, Hyperinsulinemia
    View official trial listing →
  • Completed NCT NCT00018382

    Insulin, Neurogenetics and Memory in Alzheimer's Disease

    Not yet reported US Department of Veterans Affairs Est. completion 2003-03 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00025753

    Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution

    Not yet reported National Center for Research Resources (NCRR) 1 site
    Other conditions: HIV Infections, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00032487

    Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)

    Not yet reported VA Office of Research and Development 1791 participants Est. completion 2008-05-30 21 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00039663

    Endothelial Dysfunction as a Risk Factor in HIV Study

    Not yet reported National Institutes of Health Clinical Center (CC) 75 participants Est. completion 2005-10 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00044447

    Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione

    Not yet reported Sanofi 170 participants Est. completion 2002-09 1 site
    Other conditions: Diabetes Mellitus, Non-Insulin-Dependent
    View official trial listing →
  • Completed NCT NCT00044460

    Efficacy and Safety In Poorly Controlled Type 2 Diabetics

    Not yet reported GlaxoSmithKline 142 participants Est. completion 2003-04-10
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00046462

    Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment

    Not yet reported Sanofi 240 participants Est. completion 2004-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00062764

    Treating Nonalcoholic Steatohepatitis With Pioglitazone

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 18 participants Est. completion 2009-02 1 site
    Other conditions: Hepatitis
    View official trial listing →
  • Completed NCT NCT00063622

    Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 247 participants Est. completion 2009-09 8 sites
    Other conditions: Liver Diseases
    View official trial listing →
  • Completed NCT NCT00065065

    A Trial of Rosiglitazone for Ulcerative Colitis

    Not yet reported James Lewis 105 participants Est. completion 2008-01 13 sites
    Other conditions: Ulcerative Colitis, Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT00081328

    Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 699 participants Est. completion 2014-02 16 sites
    Other conditions: Diabetes Mellitus, Type II
    View official trial listing →
  • Completed NCT NCT00086502

    Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

    Not yet reported Merck Sharp & Dohme LLC 353 participants Est. completion 2005-11
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00086515

    Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 701 participants Est. completion 2007-02-02
    Other conditions: Diabetes Mellitus, Type II
    View official trial listing →
  • Completed NCT NCT00091949

    Insulin Resistance Intervention After Stroke Trial

    Not yet reported Yale University 3876 participants Est. completion 2015-11 183 sites
    Cardiovascular disease Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00095654

    The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial

    Not yet reported Gerstein, Hertzel, MD 5000 participants Est. completion 2006-10
    PrediabetesCardiovascular disease Other conditions: Glucose Metabolism Disorders
    View official trial listing →
  • Completed NCT NCT00097279

    Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 230 participants Est. completion 2005-08 73 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT00098852

    Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer

    Not yet reported University of California, San Francisco 25 participants 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00099853

    Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes

    Not yet reported Novartis Pharmaceuticals 362 participants Est. completion 2008-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00106808

    Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes

    Not yet reported Bristol-Myers Squibb 1440 participants Est. completion 2006-08 195 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00108615

    Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance

    Not yet reported US Department of Veterans Affairs 48 participants Est. completion 2007-12 1 site
    Other conditions: Glucose Metabolism Disorders, Diabetes
    View official trial listing →
  • Completed NCT NCT00110851

    Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

    Not yet reported Wellstat Therapeutics 90 participants Est. completion 2007-08 20 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00115661

    Use of Rosiglitazone in the Treatment of Endometriosis

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 25 participants Est. completion 2006-05 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT00116545

    TART - Troglitazone Atherosclerosis Regression Trial

    Not yet reported, Not yet reported Parke-Davis 288 participants Est. completion 2000-04 1 site
    Other conditions: Atherosclerosis, Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT00116792

    PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions

    Not yet reported, Not yet reported Gold, Herman K., MD 120 participants 1 site
    Cardiovascular disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00116922

    A Lifestyle and Combination Medication Therapy Diabetes Prevention Study

    Not yet reported Samuel Lunenfeld Research Institute, Mount Sinai Hospital 207 participants Est. completion 2010-01 2 sites
    Prediabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00119496

    Rosiglitazone Versus Theophylline in Asthmatic Smokers

    Not yet reported, Not yet reported University of Glasgow 79 participants Est. completion 2007-06 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00121966

    South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus

    Not yet reported Odense University Hospital 400 participants Est. completion 2007-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT00123227

    Rosiglitazone Plaque Study

    Not yet reported Royal Brompton & Harefield NHS Foundation Trust 60 participants Est. completion 2005-05 2 sites
    Type 2 diabetes Other conditions: Vascular Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT00135330

    An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus

    Not yet reported AstraZeneca 137 participants Est. completion 2008-07 19 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00138554

    Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes

    Not yet reported Novartis 318 participants Est. completion 2006-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00143624

    Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

    Not yet reported University of British Columbia 50 participants Est. completion 2009-12 1 site
    Other conditions: Atherosclerosis, HIV Infections
    View official trial listing →
  • Completed NCT NCT00145340

    Pioglitazone Treatment in Polycystic Ovary Syndrome

    Not yet reported Odense University Hospital 30 participants Est. completion 2007-01 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00149383

    Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria

    Not yet reported, Not yet reported Mahidol University 140 participants Est. completion 2006-01 1 site
    Other conditions: Falciparum Malaria
    View official trial listing →
  • Completed NCT NCT00153166

    ARREST PAD (Peripheral Arterial Disease)

    Not yet reported, Not yet reported Brigham and Women's Hospital 76 participants Est. completion 2011-12 1 site
    Alcohol use disorder Other conditions: Arterial Occlusive Disease, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00154011

    Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.

    Not yet reported Technische Universität Dresden 24 participants Est. completion 2006-06 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00154037

    Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.

    Not yet reported Technische Universität Dresden 40 participants Est. completion 2006-09 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT00155350

    Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients

    Not yet reported National Taiwan University Hospital 120 participants Est. completion 2007-12 1 site
    Other conditions: Coronary Atherosclerosis, Inflammation, Coronary Heart Disease
    View official trial listing →
  • Terminated NCT NCT00159211

    Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin

    Not yet reported Assistance Publique - Hôpitaux de Paris 28 participants Est. completion 2007-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Suspended NCT NCT00166803

    The Impact of Rosiglitazone on Regression of Atherosclerosis

    Not yet reported National Taiwan University Hospital 60 participants 1 site
    Other conditions: Diabetes Mellitus, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00169832

    Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial

    Not yet reported Laval University 193 participants Est. completion 2007-07 9 sites
    Other conditions: Diabetes, Coronary Artery Bypass Grafting
    View official trial listing →
  • Withdrawn NCT NCT00169923

    Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease

    Not yet reported, Not yet reported Leiden University Medical Center 200 participants Est. completion 2009-05 2 sites
    Chronic kidney disease Other conditions: Inflammation
    View official trial listing →
  • Completed NCT NCT00174993

    Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes

    Not yet reported Takeda 4373 participants Est. completion 2005-01 19 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00178841

    Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL

    Not yet reported Vanderbilt University 4 participants Est. completion 2007-03 1 site
    Other conditions: Cutaneous T-cell Lymphoma, Mycosis Fungoides, Sezary Syndrome
    View official trial listing →
  • Completed NCT NCT00182052

    Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer

    Not yet reported Massachusetts General Hospital 100 participants Est. completion 2003-08 2 sites
    Other conditions: Adenocarcinoma of the Prostate, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00186537

    Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.

    Not yet reported Stanford University 47 participants Est. completion 2008-09 1 site
    Other conditions: Insulin Resistance, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00189163

    Pioglitazone in Hepatitis C

    Not yet reported University of Michigan 40 participants 1 site
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00193648

    Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)

    Not yet reported Northwell Health 21 participants Est. completion 2007-10 2 sites
    Other conditions: Focal Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT00194896

    Preferred Treatment of Type 1.5 Diabetes

    Not yet reported University of Washington 64 participants Est. completion 2008-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00197132

    Study In Patients With Insulin Resistance

    Not yet reported GlaxoSmithKline 18 participants Est. completion 2003-08 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Terminated NCT NCT00203632

    Glitazones and Endothelial Function (GATE)

    Not yet reported University of Calgary 40 participants Est. completion 2007-10 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00203996

    Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

    Not yet reported University of Chicago 37 participants Est. completion 2008-06 1 site
    Obstructive sleep apnea Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00207402

    Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

    Not yet reported Brooke Army Medical Center 34 participants Est. completion 2010-07 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Terminated NCT NCT00212004

    Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)

    Not yet reported National Cerebral and Cardiovascular Center, Japan 630 participants Est. completion 2018-04 1 site
    Cardiovascular disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00214253

    Islet Transplantation in Type 1 Diabetic Patients

    Not yet reported University of Wisconsin, Madison 14 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00219440

    A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS

    Not yet reported Pennington Biomedical Research Center 60 participants Est. completion 2006-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00220961

    Actos Now for Prevention of Diabetes (ACT NOW)

    Not yet reported The University of Texas Health Science Center at San Antonio 602 participants Est. completion 2010-04 8 sites
    PrediabetesType 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00225225

    Rosiglitazone-Induced Weight Gain

    Not yet reported Stanford University 45 participants Est. completion 2005-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00225264

    Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.

    Not yet reported Takeda 458 participants Est. completion 2006-05 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00225277

    Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Takeda 547 participants Est. completion 2007-10 79 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT00225342

    Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina

    Not yet reported University of Glasgow 60 participants 1 site
    Type 2 diabetes Other conditions: Angina Pectoris
    View official trial listing →
  • Terminated NCT NCT00225355

    Rosiglitazone Versus Placebo in Chronic Stable Angina

    Not yet reported University of Glasgow 80 participants Est. completion 2006-11 1 site
    Metabolic syndrome Other conditions: Angina Pectoris
    View official trial listing →
  • Terminated NCT NCT00226330

    GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

    Not yet reported AstraZeneca 1100 participants Est. completion 2006-12 171 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00231387

    Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus

    Not yet reported GlaxoSmithKline 60 participants Est. completion 2005-05 1 site
    Other conditions: Non-insulin-dependent Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00231894

    Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia

    Not yet reported Nathan Kline Institute for Psychiatric Research 56 participants Est. completion 2010-01 1 site
    Other conditions: Diabetes, Schizophrenia, Insulin Resistance, Cognitive Impairment
    View official trial listing →
  • Withdrawn NCT NCT00232362

    Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus

    Not yet reported Texas Tech University Health Sciences Center Est. completion 2008-06
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00232583

    Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

    Not yet reported University of Texas Southwestern Medical Center 58 participants Est. completion 2011-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00241423

    Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes

    Not yet reported AstraZeneca 30 participants Est. completion 2007-06 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00242177

    Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability

    Not yet reported University of Illinois at Chicago 30 participants Est. completion 2005-10 1 site
    Other conditions: Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Completed NCT NCT00242619

    Insulin Resistance in Patients With Mood Disorder

    Not yet reported Stanford University 12 participants Est. completion 2009-12 1 site
    Other conditions: Depression, Bipolar Disorder, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00256646

    Markers and Mechanisms of Vascular Disease in Type II Diabetes

    US Department of Veterans Affairs 298 participants Est. completion 2008-05 17 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00274495

    Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver

    Not yet reported Beth Israel Medical Center 30 participants Est. completion 2007-10 1 site
    Other conditions: Chronic Hepatitis C Infection, Fatty Liver
    View official trial listing →
  • Completed NCT NCT00279045

    Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

    Not yet reported GlaxoSmithKline 4426 participants Est. completion 2006-06-19 490 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00280865

    GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes

    Not yet reported AstraZeneca 500 participants Est. completion 2003-06 110 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00283049

    Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control

    Not yet reported Sanofi 390 participants Est. completion 2008-11 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00285142

    Effect of Rosiglitazone

    Not yet reported University Hospital, Montpellier 12 participants Est. completion 2004-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00285844

    Integrating the Genetic and Metabolic Faces of Obesity

    Not yet reported Stanford University 88 participants Est. completion 2012-10 1 site Stand-alone
    Metabolic syndrome Other conditions: Insulin Resistance, Obesity
    View official trial listing →
  • Completed NCT NCT00290940

    Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917

    Not yet reported Daiichi Sankyo 400 participants Est. completion 2007-04 66 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00295633

    A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

    Not yet reported AstraZeneca 565 participants Est. completion 2008-10 133 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00297063

    BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-

    Not yet reported GlaxoSmithKline 350 participants Est. completion 2007-05-31 14 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00306176

    Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus

    Not yet reported Aristotle University Of Thessaloniki 100 participants Est. completion 2006-10 1 site
    Other conditions: Type II Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT00306826

    Pioglitazone in Impaired Glucose Tolerance

    Not yet reported University of Leipzig 120 participants Est. completion 2009-05 7 sites
    Other conditions: Glucose Metabolism Disorders
    View official trial listing →
  • Completed NCT NCT00309309

    Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant

    Not yet reported Mario Negri Institute for Pharmacological Research 10 participants Est. completion 2007-07 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Status unknown NCT NCT00309660

    Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis

    Not yet reported, Not yet reported Herlev Hospital 20 participants Est. completion 2007-06 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00314561

    The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome

    Not yet reported Korea University Anam Hospital 40 participants Est. completion 2006-12 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00315146

    Optimizing Body Composition for Function in Older Adults

    Not yet reported Wake Forest University Health Sciences 88 participants Est. completion 2007-04 1 site
    Other conditions: Obesity, Overweight With Indications for Weight Loss
    View official trial listing →
  • Completed NCT NCT00318630

    The Effect Of AVANDIA On The Late Asthmatic Response

    Not yet reported GlaxoSmithKline 26 participants Est. completion 2006-06-30 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00322868

    Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease

    Not yet reported University Hospitals Cleveland Medical Center 21 participants Est. completion 2007-04 1 site
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00328393

    Effect of Pioglitazone on Ambulatory Blood Pressure

    Not yet reported University of Erlangen-Nürnberg Medical School 2 participants Est. completion 2011-01 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00331487

    Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

    Not yet reported Takeda 719 participants Est. completion 2004-03 67 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00337350

    Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment

    Not yet reported Massachusetts General Hospital 20 participants Est. completion 2011-01 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00348712

    Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 301 participants Est. completion 2008-03-05 74 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00353587

    Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin

    Not yet reported, Not yet reported Gilead Sciences 396 participants Est. completion 2007-11 67 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00361868

    Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI

    Not yet reported Solvay Pharmaceuticals 88 participants Est. completion 2007-12 70 sites
    Other conditions: Dyslipidemia, Glucose Metabolism Disorder
    View official trial listing →
  • Completed NCT NCT00362726

    Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone

    Not yet reported Bristol-Myers Squibb 14 participants Est. completion 2006-11 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00364221

    Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome

    Not yet reported University of Colorado, Denver Est. completion 2006-10 1 site
    Metabolic syndrome Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00367744

    Rosiglitazone Effect on Mitochondria and Lipoatrophy

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 71 participants Est. completion 2008-12 2 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00369174

    Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia

    Not yet reported National Cancer Institute (NCI) 25 participants 1 site
    Other conditions: Oral Leukoplakia
    View official trial listing →
  • Completed NCT NCT00370305

    11ß-HSD1 and Metabolic Syndrome

    Not yet reported Charite University, Berlin, Germany 24 participants Est. completion 2008-10 1 site
    Metabolic syndromePrediabetes
    View official trial listing →
  • Completed NCT NCT00372086

    Rosiglitazone and Insulin in T1DM Adolescents

    Not yet reported The University of New South Wales 32 participants Est. completion 2005-09 1 site
    Other conditions: Type 1 Diabetes, Puberty: >Tanner 2 Breast Development or Testis >4ml
    View official trial listing →
  • Completed NCT NCT00373178

    Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes

    Not yet reported Aristotle University Of Thessaloniki 100 participants Est. completion 2008-06 2 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00376181

    Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Takeda 96 participants Est. completion 2007-05 73 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT00376870

    PIoglitazone for PrEvention of Restenosis in Diabetic Patients

    Not yet reported University of Rome Tor Vergata 160 participants Est. completion 2011-04 2 sites
    Other conditions: Coronary Atherosclerosis, Coronary Restenosis, Diabetes
    View official trial listing →
  • Completed NCT NCT00381238

    Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease

    Not yet reported GlaxoSmithKline 33 participants Est. completion 2009-02-03 7 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00388518

    A Study of Aleglitazar in Patients With Type 2 Diabetes

    Not yet reported Hoffmann-La Roche 332 participants Est. completion 2008-03 55 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00395941

    Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 40 participants Est. completion 2008-12 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00402012

    "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM

    Not yet reported Pennington Biomedical Research Center 24 participants Est. completion 2007-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00402909

    Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone

    Not yet reported Novartis Pharmaceuticals 28 participants Est. completion 2007-08 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00405015

    The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.

    Not yet reported Radboud University Medical Center 13 participants Est. completion 2008-10 1 site
    Metabolic syndrome Other conditions: Ischemia-Reperfusion Injury
    View official trial listing →
  • Status unknown NCT NCT00409097

    Effect of Rosiglitazone on ADMA in Critical Illness

    Not yet reported Amsterdam UMC, location VUmc 30 participants Est. completion 2007-12 1 site
    Other conditions: Critical Illness, Multiple Organ Failure
    View official trial listing →
  • Terminated NCT NCT00411892

    Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 196 participants Est. completion 2008-03-18 110 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00422955

    Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.

    Not yet reported GlaxoSmithKline 36 participants Est. completion 2005-10 1 site
    Other conditions: Neuropathy, Diabetic
    View official trial listing →
  • Completed NCT NCT00424762

    Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride

    Not yet reported University of Texas Southwestern Medical Center 150 participants Est. completion 2007-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00427154

    Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 227 participants Est. completion 2008-03-11 103 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00427999

    Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer

    Not yet reported Novartis Pharmaceuticals 67 participants Est. completion 2015-08 10 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00428090

    Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

    Not yet reported GlaxoSmithKline 862 participants Est. completion 2008-09-05 138 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00432276

    Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Takeda 803 participants Est. completion 2009-06 86 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00432679

    A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study

    Not yet reported GlaxoSmithKline 149 participants Est. completion 2007-03-28 4 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00433069

    Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone

    Not yet reported University Hospital, Geneva 5 participants Est. completion 2008-01 1 site
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00440375

    Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women

    Not yet reported Baskent University 82 participants Est. completion 2006-03
    Type 2 diabetes Other conditions: Obesity, Menopause
    View official trial listing →
  • Completed NCT NCT00441272

    Pioglitazone to Treat Fatty Liver in People With HIV Infection

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 100 participants 1 site
    Other conditions: HIV Infections, Hepatic Steatosis, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00443170

    A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects

    Not yet reported GlaxoSmithKline 90 participants 3 sites
    Other conditions: Healthy Subjects, Anaemia
    View official trial listing →
  • Completed NCT NCT00443755

    Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance

    Not yet reported Mayo Clinic 28 participants Est. completion 2010-08 1 site
    Type 2 diabetesMetabolic syndrome Other conditions: Insulin Resistance
    View official trial listing →
  • Terminated NCT NCT00452166

    Rosiglitazone and Insulin Resistance in Renally Impaired Patients

    Not yet reported Leiden University Medical Center 30 participants Est. completion 2008-05 1 site
    Chronic kidney disease Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00459940

    The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients

    Not yet reported University of Aarhus 20 participants Est. completion 2006-03 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00461006

    A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.

    Not yet reported Hoffmann-La Roche 176 participants Est. completion 2008-09 52 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00461058

    A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.

    Not yet reported Hoffmann-La Roche 14 participants Est. completion 2007-12 45 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00465296

    Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS

    Not yet reported Medstar Health Research Institute 200 participants Est. completion 2007-07 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00470262

    Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation

    Not yet reported VA Office of Research and Development 27 participants Est. completion 2014-06 1 site
    Metabolic syndrome Other conditions: Prediabetic State
    View official trial listing →
  • Completed NCT NCT00479986

    Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease

    Not yet reported IKFE Institute for Clinical Research and Development 92 participants Est. completion 2006-11 2 sites
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT00481429

    Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study

    Imperial College London Est. completion 2008-01 4 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00485056

    Pioglitazone on Cardiac Function and Large Arteries (PICCOLA Study)

    Not yet reported Imperial College London 24 participants Est. completion 2010-04 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00486187

    Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study

    Not yet reported Dr. Milan Gupta 103 participants Est. completion 2009-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00492700

    A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis

    Not yet reported Association pour la Recherche sur les Maladies Hépatiques Virales 63 participants 1 site
    Other conditions: Non Alcoholic Steatohepatitis
    View official trial listing →
  • Completed NCT NCT00494312

    Safety Study of Pioglitazone Compared To Glyburide on Liver Function

    Not yet reported Takeda 2120 participants Est. completion 2005-06
    Other conditions: Diabetes Mellitus, Liver
    View official trial listing →
  • Completed NCT NCT00500331

    Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

    Not yet reported GlaxoSmithKline 334 participants Est. completion 2008-02-14 136 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00501488

    Effect of Adiponectin Genetic Polymorphism on Rosiglitazone Response

    Central South University 42 participants Est. completion 2007-02 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00507494

    Influence of Pioglitazone for Renal Transplant Function in Diabetics

    Not yet reported Technische Universität Dresden Est. completion 2009-09 1 site
    Other conditions: Diabetes Mellitus, Kidney Transplantation, Proteinuria
    View official trial listing →
  • Terminated NCT NCT00510705

    Chronic Inflammatory Activation in Fat Tissue: An Atherogenic Factor in Severe Coronary Artery Disease

    Not yet reported University of Leipzig 29 participants 1 site
    Cardiovascular diseasePrediabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00511823

    The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

    Not yet reported GlaxoSmithKline 16 participants Est. completion 2007-09-21 1 site
    Other conditions: Nausea and Vomiting, Chemotherapy-Induced
    View official trial listing →
  • Status unknown NCT NCT00516880

    Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?

    Not yet reported Hospital Authority, Hong Kong 160 participants Est. completion 2008-11 2 sites
    Cardiovascular disease Other conditions: Chronic Disease, Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00521742

    Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

    Not yet reported Takeda 300 participants Est. completion 2003-01
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00522470

    Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels

    Not yet reported Baskent University 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00523913

    A Study Of BRL49653C For The Treatment Of Type 2 Diabetes

    Not yet reported GlaxoSmithKline 70 participants Est. completion 2007-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00531882

    Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers

    Not yet reported University Hospitals Cleveland Medical Center 25 participants Est. completion 2009-02 2 sites
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00532935

    MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)

    Not yet reported Merck Sharp & Dohme LLC 517 participants Est. completion 2009-10-23
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00541450

    A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 492 participants Est. completion 2010-01-16
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00541775

    Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)

    Not yet reported Merck Sharp & Dohme LLC 273 participants Est. completion 2007-03
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00545233

    A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

    Not yet reported Hoffmann-La Roche 155 participants Est. completion 2010-12 66 sites
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT00545857

    Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus

    Not yet reported Stony Brook University 15 participants Est. completion 2012-05 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00551564

    Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate

    Not yet reported GlaxoSmithKline 36 participants Est. completion 2008-09-08 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00551876

    Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)

    Not yet reported Organon and Co 214 participants Est. completion 2003-01
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00554853

    PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease

    Not yet reported University of Michigan 143 participants Est. completion 2013-01 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00567593

    Gene Regulation by Thiazolidinediones

    Not yet reported James Lewis 12 participants Est. completion 2008-03 1 site
    Other conditions: Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT00570622

    Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis

    Not yet reported Medical University of Vienna 20 participants Est. completion 2008-11 1 site
    Other conditions: Cirrhosis, Ascites, Portal Hypertension
    View official trial listing →
  • Completed NCT NCT00571506

    Effect of Thiazolidinedione Treatment Vascular Risk Markers

    Not yet reported University of Arkansas 25 participants Est. completion 2007-08 1 site
    Type 2 diabetes Other conditions: Vascular Diseases
    View official trial listing →
  • Terminated NCT NCT00571519

    Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus

    Not yet reported Daiichi Sankyo 94 participants Est. completion 2008-05-23 18 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00575471

    Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes

    Not yet reported Daiichi Sankyo Co., Ltd. 250 participants Est. completion 2008-03 3 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00603239

    Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

    Not yet reported AstraZeneca 165 participants Est. completion 2009-07 25 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00609856

    Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes

    Not yet reported Skane University Hospital 36 participants Est. completion 2006-12 1 site
    Type 2 diabetes Other conditions: Secondary Drug Failure
    View official trial listing →
  • Terminated NCT NCT00612066

    Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)

    Not yet reported Jonsson Comprehensive Cancer Center 2 participants Est. completion 2010-11 1 site
    Other conditions: Cushing's Disease
    View official trial listing →
  • Completed NCT NCT00615212

    Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects

    Not yet reported GlaxoSmithKline 23 participants Est. completion 2008-02-15 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00618072

    EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance

    Not yet reported New York Medical College 46 participants Est. completion 2011-01 1 site
    Other conditions: Hyperinsulinemia, Insulin Resistance, Obesity
    View official trial listing →
  • Completed NCT NCT00631007

    A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator

    Not yet reported InteKrin Therapeutics, Inc. 367 participants Est. completion 2009-09 66 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00633282

    Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease

    Not yet reported Xin Gao 184 participants Est. completion 2011-08 3 sites
    MASLD
    View official trial listing →
  • Completed NCT NCT00634036

    Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics

    Not yet reported Fernando Holguin 23 participants Est. completion 2012-04 2 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00637273

    A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

    Not yet reported AstraZeneca 514 participants Est. completion 2009-07 62 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00639457

    Exercise and Pioglitazone for HIV-Metabolic Syndromes

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 44 participants Est. completion 2009-12 1 site
    Type 2 diabetesCardiovascular disease Other conditions: HIV Infections, Obesity, HIV, AIDS, Lipodystrophy
    View official trial listing →
  • Completed NCT NCT00640224

    Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study

    Not yet reported Silva Arslanian 65 participants Est. completion 2015-07 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00641043

    Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone

    Not yet reported Boehringer Ingelheim 389 participants 43 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00649558

    Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg

    Not yet reported Mylan Pharmaceuticals Inc 36 participants Est. completion 2003-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00655863

    Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.

    Not yet reported Takeda 71 participants Est. completion 2009-12 2 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00656851

    Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24 participants Est. completion 2010-08 1 site
    Cardiovascular diseaseMetabolic syndrome Other conditions: HIV Infections, Insulin Resistance, HIV Lipodystrophy
    View official trial listing →
  • Completed NCT NCT00656864

    Pioglitazone Incretin Study

    Not yet reported University of Vermont 24 participants Est. completion 2010-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00663143

    Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast Formation

    Emory University 9 participants Est. completion 2010-12 3 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00665353

    Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 19 participants Est. completion 2011-12 8 sites
    Other conditions: HIV-1 and Hepatitis C Co-Infection
    View official trial listing →
  • Completed NCT NCT00671515

    Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome

    Not yet reported Joseph Calabrese, MD 23 participants Est. completion 2011-11 1 site
    Metabolic syndrome Other conditions: Depressive Disorder, Major
    View official trial listing →
  • Completed NCT NCT00672919

    Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.

    Not yet reported Takeda 305 participants Est. completion 2004-08 53 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00675740

    Physical Exercise Versus Rosiglitazone in CAD and Prediabetes

    Not yet reported University of Leipzig 45 participants Est. completion 2007-02
    Prediabetes
    View official trial listing →
  • Completed NCT NCT00676260

    Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin

    Not yet reported Takeda 29 participants Est. completion 2004-08 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00679939

    Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health

    Not yet reported GlaxoSmithKline 226 participants Est. completion 2010-09-16 42 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00680745

    Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients

    Not yet reported AstraZeneca 597 participants Est. completion 2010-05 66 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT00681733

    Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH)

    Not yet reported Govind Ballabh Pant Hospital 20 participants Est. completion 2008-12 1 site
    Other conditions: Metabolic Parameters and Liver Histology
    View official trial listing →
  • Completed NCT NCT00683878

    Add-on to Thiazolidinedione (TZD) Failures

    Not yet reported AstraZeneca 972 participants Est. completion 2010-06 89 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00688207

    Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)

    Not yet reported GlaxoSmithKline 14 participants Est. completion 2008-09 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Terminated NCT NCT00690118

    Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis

    Not yet reported University of Ulm 219 participants Est. completion 2010-06 15 sites
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Completed NCT NCT00692510

    Drug Interaction Study Between AZD3480 and Cytochrome P450

    Not yet reported AstraZeneca 18 participants Est. completion 2008-09 1 site
    Other conditions: Metabolism, Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00694759

    Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)

    Not yet reported Oregon Health and Science University 37 participants Est. completion 2011-07 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Status unknown NCT NCT00699036

    Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)

    Not yet reported Brooke Army Medical Center 165 participants Est. completion 2009-08 1 site
    MASHMASLD
    View official trial listing →
  • Status unknown NCT NCT00700856

    Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial

    Not yet reported Italian Society of Diabetology 3371 participants Est. completion 2018-12 61 sites
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Completed NCT NCT00708175

    Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.

    Not yet reported Takeda 156 participants Est. completion 2011-02 34 sites
    Other conditions: Bone Metabolism
    View official trial listing →
  • Completed NCT NCT00717457

    A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

    Not yet reported Hoffmann-La Roche 1189 participants Est. completion 2011-03 216 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00719381

    Effect of Pioglitazone on Inflammation in Cystic Fibrosis

    Not yet reported Paul Beringer 24 participants Est. completion 2009-06 1 site
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00720577

    Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.

    Not yet reported Medtronic Endovascular 164 participants Est. completion 2007-08
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT00722631

    Anti-Inflammatory Effects of Pioglitazone

    Not yet reported Kurume University 70 participants Est. completion 2012-04 1 site
    PrediabetesType 2 diabetes Other conditions: Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT00722917

    Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

    Not yet reported Takeda 323 participants Est. completion 2009-04 8 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00729326

    Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione

    Not yet reported AstraZeneca 83 participants Est. completion 2009-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00736996

    Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)

    Not yet reported University of Colorado, Denver 78 participants Est. completion 2013-12 1 site
    Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT00737347

    Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone

    Not yet reported Northwestern University 39 participants Est. completion 2008-04 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Terminated NCT NCT00742326

    Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 13 participants Est. completion 2013-01 2 sites
    Other conditions: HIV, Hepatitis C, Liver Disease, Fatty Liver, Steatosis
    View official trial listing →
  • Completed NCT NCT00745225

    Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis Patients

    Not yet reported The University of Hong Kong 160 participants Est. completion 2014-12 1 site
    Other conditions: End-stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00745914

    Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients

    Not yet reported The University of Hong Kong 22 participants Est. completion 2013-12 2 sites
    Other conditions: Endstage Renal Disease, Diabetes
    View official trial listing →
  • Status unknown NCT NCT00749047

    How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?

    Not yet reported Christchurch Hospital 12 participants Est. completion 2010-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00753896

    Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

    Not yet reported AstraZeneca 134 participants Est. completion 2009-11 26 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00754403

    Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

    Not yet reported Takeda 312 participants Est. completion 2006-10
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00762736

    Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus

    Not yet reported Takeda 704 participants Est. completion 2005-10 78 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00763139

    Inflammation and Insulin Resistance in Rheumatoid Arthritis

    Not yet reported Vanderbilt University 34 participants Est. completion 2013-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00763815

    GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone

    Not yet reported Sanofi 484 participants Est. completion 2011-06 150 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00770367

    Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes

    Not yet reported Medical University of South Carolina 36 participants Est. completion 2010-06 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00770445

    Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.

    Not yet reported Takeda 121 participants Est. completion 2010-07 18 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00770497

    Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.

    Not yet reported Takeda 172 participants Est. completion 2008-05 13 sites
    Other conditions: Inflammation, Hypertension
    View official trial listing →
  • Completed NCT NCT00770575

    Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease

    Not yet reported Takeda 148 participants Est. completion 2006-10
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00770640

    Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.

    Not yet reported Takeda 40 participants Est. completion 2010-06 9 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00770653

    Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.

    Not yet reported Takeda 305 participants Est. completion 2009-05 64 sites
    Other conditions: Diabetes Mellitus, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT00770952

    Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.

    Not yet reported Takeda 91 participants Est. completion 2008-12 17 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00771004

    Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.

    Not yet reported Takeda 63 participants Est. completion 2009-02 7 sites
    Cardiovascular diseaseType 2 diabetes Other conditions: Oxidative Stress
    View official trial listing →
  • Completed NCT NCT00772174

    Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

    Not yet reported Takeda 418 participants Est. completion 2008-02
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT00775164

    Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study

    Not yet reported University of Minnesota Est. completion 2011-02
    Other conditions: Obesity, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00780234

    Pioglitazone for Lung Cancer Chemoprevention

    Not yet reported VA Office of Research and Development 92 participants Est. completion 2017-08 2 sites Stand-alone
    Other conditions: Lung Cancer, Endobronchial Dysplasia
    View official trial listing →
  • Completed NCT NCT00782795

    Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality

    Not yet reported University of Michigan 64 participants Est. completion 2013-12 1 site
    Other conditions: Chronic Pancreatitis, Insulin Resistance, Normal or Mildly Abnormal Stool Fat Levels
    View official trial listing →
  • Completed NCT NCT00785213

    Drug-Drug Interaction Study Between Quinine Sulfate and Rosiglitazone

    Not yet reported Mutual Pharmaceutical Company, Inc. 23 participants Est. completion 2008-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00787644

    Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics (Glitz Asthma)

    Not yet reported University of Vermont 28 participants Est. completion 2013-12 1 site
    Other conditions: Asthma, Obesity
    View official trial listing →
  • Terminated NCT NCT00811356

    A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria

    Not yet reported GlaxoSmithKline 12 participants Est. completion 2009-03-30 1 site
    Other conditions: Malaria
    View official trial listing →
  • Completed NCT NCT00811681

    Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept

    Not yet reported Assistance Publique - Hôpitaux de Paris 40 participants Est. completion 2013-03 1 site
    Other conditions: Friedreich's Ataxia
    View official trial listing →
  • Terminated NCT NCT00814372

    Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

    Not yet reported Gilead Sciences 242 participants Est. completion 2010-02 26 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00815399

    Pioglitazone Versus Metformin in Type 2 Diabetes

    Not yet reported University of Campania Luigi Vanvitelli 150 participants Est. completion 2015-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00816218

    Molecular Mechanisms of Type 2 Diabetes Mellitus

    Not yet reported The University of Texas Health Science Center at San Antonio 39 participants Est. completion 2008-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00819325

    Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients

    Not yet reported Queen Elizabeth II Health Sciences Centre 50 participants Est. completion 2007-03 1 site
    Cardiovascular diseaseType 2 diabetes Other conditions: Angina Pectoris, Percutaneous Coronary Intervention
    View official trial listing →
  • Terminated NCT NCT00819910

    Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)

    Not yet reported Ahmad Slim 41 participants Est. completion 2010-05 1 site
    Other conditions: Hypertriglyceridemia in Type 4 Hyperlipidemia, Non Diabetic Subjects With Normoglycemia
    View official trial listing →
  • Terminated NCT NCT00825266

    Insulin Resistance in Pulmonary Arterial Hypertension

    Not yet reported Stanford University 2 participants Est. completion 2010-05 1 site
    Other conditions: Hypertension, Pulmonary
    View official trial listing →
  • Completed NCT NCT00831129

    A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs

    Not yet reported, Not yet reported University of Chicago 53 participants Est. completion 2011-04 1 site
    Prediabetes
    View official trial listing →
  • Completed NCT NCT00835120

    Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

    Not yet reported University Hospitals Cleveland Medical Center 34 participants Est. completion 2013-04 1 site
    Metabolic syndrome Other conditions: Bipolar Depression, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00845182

    Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function

    Not yet reported The University of Texas Health Science Center at San Antonio 43 participants Est. completion 2010-07 1 site
    Type 2 diabetesPrediabetes Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00861341

    Effects of Pioglitazone on Platelet Function

    Not yet reported University of Rochester 40 participants Est. completion 2011-06 1 site
    Other conditions: Diabetes, Platelet Function, Healthy
    View official trial listing →
  • Terminated NCT NCT00867126

    Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine

    Not yet reported University of Texas Southwestern Medical Center 6 participants Est. completion 2012-02 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Terminated NCT NCT00868140

    Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)

    Not yet reported Virginia Commonwealth University 51 participants Est. completion 2011-08 2 sites
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00894322

    A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension

    Not yet reported, Not yet reported AstraZeneca 65 participants Est. completion 2009-08 1 site Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00909597

    A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes

    Not yet reported Hoffmann-La Roche 756 participants Est. completion 2010-11 147 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00919555

    Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)

    Not yet reported, Not yet reported Phoenix Neurological Associates, LTD 28 participants Est. completion 2012-03 1 site
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Terminated NCT NCT00923949

    Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer

    Not yet reported National Cancer Institute (NCI) 1 participants Est. completion 2010-03 2 sites
    Other conditions: Non-Small-Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00926016

    Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

    Not yet reported Brooke Army Medical Center 23 participants Est. completion 2010-09 1 site
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00926341

    The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome

    Not yet reported Aligarh Muslim University 110 participants Est. completion 2008-09 1 site
    Metabolic syndrome
    View official trial listing →
  • Terminated NCT NCT00927290

    Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance

    Not yet reported French National Agency for Research on AIDS and Viral Hepatitis 40 participants Est. completion 2012-07-06 1 site
    Other conditions: Chronic Hepatitis C, Insulin Resistance
    View official trial listing →
  • Terminated NCT NCT00951379

    Pioglitazone for Oral Premalignant Lesions

    Not yet reported National Cancer Institute (NCI) 52 participants Est. completion 2014-03 13 sites
    Other conditions: Oral Leukoplakia
    View official trial listing →
  • Completed NCT NCT00953498

    Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) Lipoproteins

    Not yet reported Centre Hospitalier Universitaire Dijon 40 participants Est. completion 2012-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00964106

    Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation

    Not yet reported GlaxoSmithKline 87 participants Est. completion 2011-08-29 2 sites
    Other conditions: Drug Interactions
    View official trial listing →
  • Status unknown NCT NCT00975169

    Association Study of Genetic Polymorphisms of Candidate Genes With Thiazolidinedione-Related Peripheral Edema and Drug Responsiveness

    National Taiwan University Hospital 400 participants 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00975286

    24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

    Not yet reported Sanofi 446 participants Est. completion 2011-08 140 sites Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00982202

    Pioglitazone in Alzheimer Disease

    Not yet reported National Institute on Aging (NIA) 25 participants Est. completion 2005-01 2 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Status unknown NCT NCT00991055

    Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes

    Not yet reported National Cheng-Kung University Hospital 40 participants Est. completion 2010-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00994175

    A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 15 participants Est. completion 2016-06-24 2 sites
    Other conditions: Severe, Refractory Asthma, Airway Inflammation, Airflow Obstruction
    View official trial listing →
  • Completed NCT NCT00994682

    University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)

    Not yet reported University of Florida 176 participants Est. completion 2014-12 1 site
    MASHMASLDType 2 diabetes
    View official trial listing →
  • Completed NCT NCT00995995

    Evaluation of the Duration of Oral Combination Therapy in Type 2 Diabetes, Prior to the Initiation of Insulin in the UK

    GlaxoSmithKline 7641 participants Est. completion 2009-02
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01001013

    Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects

    Not yet reported LG Life Sciences 24 participants Est. completion 2009-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01001611

    An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus

    Not yet reported Chong Kun Dang Pharmaceutical 173 participants Est. completion 2012-01 9 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01006018

    DPP-4 Inhibition and TZD for DM Prevention

    Not yet reported Emory University 3 participants Est. completion 2011-12 2 sites
    Other conditions: Prediabetic State
    View official trial listing →
  • Status unknown NCT NCT01010243

    Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial

    Not yet reported, Not yet reported University of Regensburg 54 participants Est. completion 2016-10 6 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01019356

    Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome

    Not yet reported Jean-Patrice Baillargeon 52 participants Est. completion 2021-07 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01023620

    HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)

    Not yet reported University of Texas Southwestern Medical Center 4 participants Est. completion 2010-05-31 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT01030679

    Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

    Not yet reported Chong Kun Dang Pharmaceutical 214 participants Est. completion 2008-10 8 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01040819

    Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?

    Not yet reported Baylor College of Medicine 25 participants Est. completion 2011-12 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01043029

    A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment

    Not yet reported Hoffmann-La Roche 302 participants Est. completion 2012-07 80 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01055223

    Fracture Risk With Thiazolidinediones

    GlaxoSmithKline 98483 participants Est. completion 2010-03
    Other conditions: Fractures, Bone, Type II Diabetes
    View official trial listing →
  • Completed NCT NCT01068444

    The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 90 participants Est. completion 2020-07 2 sites
    Other conditions: Hepatitis
    View official trial listing →
  • Completed NCT NCT01068860

    To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

    Not yet reported Novartis 246 participants Est. completion 2010-08 52 sites Stand-alone
    Type 2 diabetesPrediabetes
    View official trial listing →
  • Completed NCT NCT01077323

    A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents

    AstraZeneca 363766 participants Est. completion 2008-03 1 site
    Type 2 diabetes Other conditions: Healthy Subjects (Treated With no Diabetes Therapies)
    View official trial listing →
  • Completed NCT NCT01087567

    INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes

    Not yet reported Ohio University 23 participants Est. completion 2014-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01088594

    A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers

    Not yet reported Solvay Pharmaceuticals 12 participants Est. completion 2010-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01088919

    A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy Subjects

    Not yet reported Astellas Pharma Inc 64 participants Est. completion 2009-12 1 site
    Other conditions: Healthy, Pharmacokinetics of ASP1941
    View official trial listing →
  • Completed NCT NCT01095666

    A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

    Not yet reported AstraZeneca 1484 participants Est. completion 2013-03 33 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01100619

    A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors

    Not yet reported Exelixis 40 participants 5 sites
    Other conditions: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Huerthle Cell Thyroid Cancer, Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01106131

    Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin

    Not yet reported Chong Kun Dang Pharmaceutical 253 participants Est. completion 2012-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01106651

    A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus

    Not yet reported Janssen Research & Development, LLC 716 participants Est. completion 2013-05 86 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01106690

    The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)

    Not yet reported Janssen Research & Development, LLC 344 participants Est. completion 2012-07 83 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01135394

    Pharmacogenomics of Thiazolidinediones

    Not yet reported University of Maryland, Baltimore 114 participants Est. completion 2018-05-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01147627

    Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

    Not yet reported Sun Yat-sen University 416 participants Est. completion 2012-12 25 sites
    Type 2 diabetes Other conditions: Newly Diagnosed
    View official trial listing →
  • Completed NCT NCT01150981

    Effect of Rosiglitazone on the Vascular Biology of Human Fat Tissue

    Not yet reported University of Massachusetts, Worcester 35 participants Est. completion 2010-04 1 site
    Metabolic syndrome Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01151670

    Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors

    Not yet reported Wake Forest University Health Sciences 18 participants Est. completion 2014-08 1 site
    Other conditions: Brain Neoplasms, Malignant, Brain Neoplasms, Benign, Malignant Meningioma, Glioblastoma Multiforme, Anaplastic Astrocytoma
    View official trial listing →
  • Completed NCT NCT01156597

    Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes

    Not yet reported University of Miami 30 participants Est. completion 2010-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT01157975

    Study the Relationship Between Obesity and Hepatitis C Replication

    Not yet reported University of California, San Diego Est. completion 2014-09 2 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01161394

    Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study

    Not yet reported University at Buffalo 24 participants Est. completion 2003-10 1 site
    Other conditions: Inflammation
    View official trial listing →
  • Completed NCT NCT01165190

    Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans

    Arizona State University 20 participants Est. completion 2010-05 2 sites
    Other conditions: Type II Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01174056

    Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging

    Not yet reported Washington University School of Medicine 39 participants Est. completion 2014-03 1 site
    Other conditions: Lung Inflammation
    View official trial listing →
  • Status unknown NCT NCT01175486

    Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy

    Not yet reported Taipei Veterans General Hospital, Taiwan 200 participants Est. completion 2015-12 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Withdrawn NCT NCT01184144

    Endometriosis: Immunomodulation

    Not yet reported, Not yet reported University of Wisconsin, Madison Est. completion 2012-05
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT01186250

    Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation

    Not yet reported Stanford University 18 participants Est. completion 2013-12 1 site
    Other conditions: Cardiac Allograft Vasculopathy
    View official trial listing →
  • Completed NCT NCT01204294

    Comprehensive Add on Study in Japan

    Not yet reported Boehringer Ingelheim 574 participants Est. completion 2012-01 43 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01205282

    Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO)

    Not yet reported Evdokia Anagnostou 28 participants Est. completion 2015-09 1 site
    Other conditions: Autism Spectrum Disorders
    View official trial listing →
  • Completed NCT NCT01209143

    A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

    Not yet reported Genentech, Inc. 52 participants Est. completion 2012-03 3 sites
    Other conditions: Solid Cancers
    View official trial listing →
  • Completed NCT NCT01217073

    A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)

    Not yet reported Merck Sharp & Dohme LLC 685 participants Est. completion 2013-04-01
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01230749

    A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 89 participants Est. completion 2011-06
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01253928

    Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRD

    Not yet reported Centre Hospitalier Universitaire Vaudois 16 participants 1 site
    Other conditions: ESRD
    View official trial listing →
  • Completed NCT NCT01258322

    Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients

    Not yet reported Huashan Hospital 70 participants Est. completion 2008-09
    Other conditions: Peritoneal Dialysis, Pioglitazone, Hypertriglyceridemia, Insulin Resistance, Inflammation
    View official trial listing →
  • Completed NCT NCT01276327

    Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components

    Not yet reported Boehringer Ingelheim 64 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01280123

    Pioglitazone in Early Parkinson's Disease

    Not yet reported University of Rochester 210 participants Est. completion 2014-05 38 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01287598

    BAY73-4506 Probe Substrate Study

    Not yet reported Bayer 41 participants Est. completion 2018-07-30 4 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Terminated NCT NCT01289639

    Insulin Resistance in Non-alcoholic Fatty Liver Disease

    Not yet reported VA Office of Research and Development 11 participants Est. completion 2014-08 1 site
    Other conditions: Fatty Liver
    View official trial listing →
  • Completed NCT NCT01301027

    Effect of Adipokines in Hemodialysis Patients

    Not yet reported University of Utah 95 participants Est. completion 2015-12 2 sites
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01318122

    Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

    Not yet reported, Not yet reported Takeda 336 participants Est. completion 2009-08
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01331967

    The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT)

    Not yet reported Korea University Anam Hospital 94 participants Est. completion 2013-08 1 site
    Other conditions: Diabetic Stable Angina, Diabetic Unstable Angina
    View official trial listing →
  • Completed NCT NCT01332071

    Avandamet Bioequivalence Study Brazil - Fed Administration

    Not yet reported GlaxoSmithKline 26 participants Est. completion 2009-12-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01346254

    Glucose Control in Pre-Diabetic Renal Transplant Patients

    Not yet reported Marcus Saemann 51 participants Est. completion 2011-11 1 site
    Prediabetes Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01352182

    Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 12 participants Est. completion 2017-01 1 site
    Other conditions: Severe Sepsis, Septic Shock
    View official trial listing →
  • Completed NCT NCT01395784

    Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone

    Not yet reported New York State Psychiatric Institute 32 participants Est. completion 2014-04 1 site
    Other conditions: Opioid Abuse
    View official trial listing →
  • Terminated NCT NCT01395797

    Pioglitazone for Heroin and for Nicotine Dependence

    Not yet reported, Not yet reported New York State Psychiatric Institute 82 participants Est. completion 2014-06 1 site
    Other conditions: Heroin Dependence, Nicotine Dependence
    View official trial listing →
  • Completed NCT NCT01402076

    A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects

    Not yet reported Vanda Pharmaceuticals 24 participants Est. completion 2011-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT01406704

    Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH

    Not yet reported Seoul St. Mary's Hospital 26 participants Est. completion 2013-12
    MASH
    View official trial listing →
  • Completed NCT NCT01421459

    A Study in Adults With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 759 participants Est. completion 2012-09 62 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01431521

    Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)

    Not yet reported Merck Sharp & Dohme LLC 31 participants Est. completion 2012-10-01
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT01432405

    Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes

    Not yet reported Baylor College of Medicine 24 participants Est. completion 2009-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01453049

    An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients

    Not yet reported GlaxoSmithKline 86 participants Est. completion 2010-10 12 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01456117

    Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants

    Not yet reported Takeda 61 participants Est. completion 2012-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01468181

    A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 394 participants Est. completion 2013-12 14 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01471808

    Effects of Different Early Intensive Therapies on Long-term β-cell Function

    Not yet reported Sun Yat-sen University 264 participants Est. completion 2018-12
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01472497

    Effects of Pioglitazone in Hypertensive Patients

    Not yet reported Tottori University Hospital 16 participants Est. completion 2012-03 1 site
    Other conditions: Hypertension, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01489943

    A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2011-11-10 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Terminated NCT NCT01517165

    Pioglitazone to Treat Opioid Withdrawal Symptoms

    Not yet reported National Institute on Drug Abuse (NIDA) 24 participants Est. completion 2015-02-02 1 site
    Other conditions: Opioid-Related Disorders
    View official trial listing →
  • Completed NCT NCT01559857

    Pioglitazone in Patients With Mood Disorders

    Not yet reported Stanford University 37 participants Est. completion 2014-06 1 site
    Other conditions: Major Depressive Disorder, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01574820

    Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery Disease

    Not yet reported National Cheng-Kung University Hospital 105 participants Est. completion 2011-07
    PrediabetesCardiovascular disease Other conditions: Insulin Resistance, Glucose Intolerance
    View official trial listing →
  • Completed NCT NCT01577095

    Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy

    Not yet reported China Medical University Hospital 49 participants Est. completion 2007-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01588470

    Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)

    Not yet reported The University of Texas Health Science Center at San Antonio 130 participants Est. completion 2011-12
    Type 2 diabetes Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT01589445

    Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects

    Not yet reported University of Dhaka 77 participants Est. completion 2010-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01593371

    Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients

    Not yet reported Tehran University of Medical Sciences 98 participants Est. completion 2012-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01614301

    Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma

    Not yet reported, Not yet reported University of Regensburg 136 participants Est. completion 2016-05 1 site
    Other conditions: Advanced Melanoma
    View official trial listing →
  • Completed NCT NCT01637935

    Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

    Takeda 193099 participants Est. completion 2014-08
    Other conditions: Diabetes, Bladder Cancer
    View official trial listing →
  • Completed NCT NCT01686711

    A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322

    Not yet reported Takeda 207 participants Est. completion 2013-12 25 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT01695707

    Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients

    Not yet reported University of Rochester Est. completion 2014-06 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Terminated NCT NCT01703260

    Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis

    Not yet reported AstraZeneca 20 participants Est. completion 2014-09 4 sites
    Other conditions: Nonalcoholic Steatohapatitis
    View official trial listing →
  • Completed NCT NCT01706211

    A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes

    Not yet reported National Taiwan University Hospital 77 participants Est. completion 2000-04 1 site
    Other conditions: Diabetes Mellitus Non Insulin Dependent Oral Agent Therapy
    View official trial listing →
  • Terminated NCT NCT01717040

    Pioglitazone for the Treatment of Bipolar Depression

    Not yet reported University Hospitals Cleveland Medical Center 37 participants Est. completion 2016-03 1 site
    Other conditions: Bipolar Disorder, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01748994

    Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women

    Not yet reported Pennington Biomedical Research Center 63 participants Est. completion 2016-12 2 sites
    Metabolic syndrome Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01777282

    A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus

    Not yet reported GlaxoSmithKline 374 participants Est. completion 2015-01-27 49 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01799850

    The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle

    Not yet reported East Tennessee State University 12 participants Est. completion 2004-03 1 site
    Other conditions: Diabetes Type 2
    View official trial listing →
  • Completed NCT NCT01817400

    Mediators of Abnormal Reproductive Function in Obesity (MARO)

    Not yet reported University of Colorado, Denver 10 participants Est. completion 2014-12 1 site
    Other conditions: Infertility, Female, Obesity
    View official trial listing →
  • Completed NCT NCT01838317

    A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

    Not yet reported University of Texas Southwestern Medical Center 14 participants Est. completion 2017-09-20 1 site
    Other conditions: Cancer of the Pancreas
    View official trial listing →
  • Completed NCT NCT01872780

    Identification of Null Allelic Variant of CYP2C8 In A Korean Population

    Not yet reported Inje University 11 participants Est. completion 2009-03
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01895569

    Triple Therapy in Type 2 Diabetic Patients

    Not yet reported University of Pavia 64 participants Est. completion 2016-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01911728

    Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

    Not yet reported Astellas Pharma Europe B.V. 14 participants Est. completion 2012-02-21 2 sites
    Other conditions: Pharmacokinetics of MDV3100, Castration Resistant Prostate Cancer (CRPC)
    View official trial listing →
  • Terminated NCT NCT01931566

    Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

    Not yet reported Takeda 3494 participants Est. completion 2018-09-06 55 sites
    Other conditions: Mild Cognitive Impairment Due to Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT01935466

    Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"

    Post Graduate Institute of Medical Education and Research, Chandigarh 6107 participants Est. completion 2021-10 1 site
    Other conditions: Bladder Cancer
    View official trial listing →
  • Completed NCT NCT01935804

    Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes

    Not yet reported King Abdulaziz University 440 participants Est. completion 2014-01 1 site
    Type 2 diabetes Other conditions: Diabetes Mellitus, Glucose Metabolism Disorders
    View official trial listing →
  • Completed NCT NCT01945242

    Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"

    Takeda 1374 participants Est. completion 2014-06
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01972724

    Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy

    Not yet reported Takeda 114 participants Est. completion 2016-10-17 9 sites
    Other conditions: Type II Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01990300

    Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus

    Takeda 3281 participants Est. completion 2015-03-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02003014

    Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"

    Takeda 899 participants Est. completion 2012-01
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT02015780

    Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

    Not yet reported Takeda Est. completion 2016-01 30 sites
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT02024971

    Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus

    Takeda 1103 participants Est. completion 2013-11
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02027103

    Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes Patients

    Not yet reported Tehran University of Medical Sciences 102 participants Est. completion 2012-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02043054

    Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

    Not yet reported University of Leicester 90 participants Est. completion 2017-09-29 1 site Added to GLP-1
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Terminated NCT NCT02072096

    A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)

    Not yet reported Eli Lilly and Company 192 participants Est. completion 2015-10 34 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02098733

    Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus

    Takeda 1168 participants Est. completion 2014-05
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02098746

    Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone

    Takeda 294 participants Est. completion 2014-07
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02105792

    PROMASTER - PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes

    Royal Devon and Exeter NHS Foundation Trust 820 participants Est. completion 2016-05 5 sites
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02133118

    Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.

    Medical Research Foundation, The Netherlands 16293 participants Est. completion 2014-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02140645

    Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy

    Boehringer Ingelheim 166613 participants Est. completion 2015-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02142309

    Glycemic Durability After Metformin Failure

    Not yet reported University of Campania Luigi Vanvitelli 450 participants Est. completion 2017-01 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02172235

    Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 20 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02181842

    Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>

    Takeda 246 participants Est. completion 2011-06-30
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02183337

    Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 20 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02183636

    Relative Bioavailability of Two Fixed Dose Combination Tablets of Linagliptin/Pioglitazone Compared With Single Linagliptin and Pioglitazone Tablets Administered Together to Healthy Male and Female Subjects

    Not yet reported Boehringer Ingelheim 39 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02188186

    Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients

    Not yet reported Seoul National University Bundang Hospital 200 participants Est. completion 2018-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02197078

    Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin

    Boehringer Ingelheim 189426 participants Est. completion 2019-02-26 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02219750

    Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients

    Not yet reported Mackay Memorial Hospital 181 participants Est. completion 2016-08 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02231021

    The Practical Evidence of Antidiabetic Combination Therapy in Korea

    Not yet reported Kun-Ho Yoon 216 participants Est. completion 2019-01-28 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02236962

    Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment

    Not yet reported Bayside Health 42 participants 1 site Stand-alone
    Type 2 diabetesCardiovascular disease Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT02265276

    A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease

    Not yet reported Command Hospital, India 100 participants Est. completion 2015-09 1 site
    Other conditions: Fatty Liver
    View official trial listing →
  • Completed NCT NCT02276365

    Bioavailability of BI 10773 and Pioglitazone in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 20 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02278562

    Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2

    Not yet reported VA Office of Research and Development 33 participants Est. completion 2017-03-01 1 site
    Other conditions: ESRD
    View official trial listing →
  • Terminated NCT NCT02284906

    AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

    Not yet reported Takeda 40 participants Est. completion 2018-05-08 43 sites
    Other conditions: Mild Cognitive Impairment Due to Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02292290

    Trial for People With Established Type 2 Diabetes During Ramadan

    Not yet reported University of Leicester 99 participants Est. completion 2012-12 2 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT02303405

    Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus

    Not yet reported Charles Drew University of Medicine and Science 22 participants Est. completion 2017-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02305069

    Effect of Obesity-derived Cytokines on Protein Turnover and Carbohydrate Metabolism in Human Skeletal Muscle

    Not yet reported University of Nottingham 26 participants Est. completion 2012-09 1 site
    Other conditions: Obesity, Sarcopenia
    View official trial listing →
  • Completed NCT NCT02338999

    Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)

    Not yet reported, Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 88 participants Est. completion 2020-07-14 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT02342067

    Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination

    Not yet reported Tobira Therapeutics, Inc. 20 participants Est. completion 2015-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02347813

    Preventing Squamous Cell Skin Cancer

    Not yet reported University of Rochester 12 participants Est. completion 2019-06-01
    Other conditions: Squamous Cell Carcinoma of the Skin
    View official trial listing →
  • Terminated NCT NCT02365233

    Fatty Liver Study in Patients With Type II Diabetes

    Not yet reported The University of Texas Medical Branch, Galveston 5 participants Est. completion 2016-12-31 1 site
    Other conditions: Type II Diabetes, Nonalcoholic Fatty Liver
    View official trial listing →
  • Status unknown NCT NCT02426294

    Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin

    Not yet reported Pusan National University Hospital 154 participants Est. completion 2016-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02429232

    A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers

    Not yet reported National Taiwan University Hospital 160 participants Est. completion 2017-12
    Other conditions: Osteoporosis, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02456428

    Incretin-based Drugs and the Risk of Heart Failure

    Canadian Network for Observational Drug Effect Studies, CNODES 1499650 participants Est. completion 2015-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02473627

    A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS

    Not yet reported Daiichi Sankyo 18 participants Est. completion 2015-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02475499

    Incretin-based Drugs and Pancreatic Cancer

    Canadian Network for Observational Drug Effect Studies, CNODES 886172 participants Est. completion 2015-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02526615

    Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes

    Not yet reported Turku University Hospital 48 participants Est. completion 2001-12 3 sites
    Type 2 diabetes Other conditions: Insulin Sensitivity
    View official trial listing →
  • Withdrawn NCT NCT02585765

    Skin Blood Flow Response to Insulin Iontophoresis in Pressure Ulcers of SCI

    Not yet reported James J. Peters Veterans Affairs Medical Center Est. completion 2018-04-01 1 site
    Other conditions: Spinal Cord Injury, Pressure Ulcers
    View official trial listing →
  • Active, not recruiting NCT NCT02592317

    A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

    Not yet reported Aragon Pharmaceuticals, Inc. 23 participants Est. completion 2027-12-31 3 sites
    Other conditions: Prostatic Neoplasms, Castration-Resistant
    View official trial listing →
  • Completed NCT NCT02616666

    A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients

    Not yet reported University of Liverpool 632 participants Est. completion 2025-12-12 132 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02653209

    TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.

    Not yet reported Royal Devon and Exeter NHS Foundation Trust 525 participants Est. completion 2021-01 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02687425

    Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous Leukemia

    Not yet reported Meng Li 20 participants Est. completion 2017-06
    Other conditions: Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    View official trial listing →
  • Completed NCT NCT02689843

    Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS

    Not yet reported Shiraz University of Medical Sciences 90 participants Est. completion 2018-12-30 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT02697617

    Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease

    Not yet reported Indiana University 18 participants Est. completion 2020-01 1 site
    Other conditions: Polycystic Kidney Disease
    View official trial listing →
  • Terminated NCT NCT02730195

    Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia

    Not yet reported Emory University 9 participants Est. completion 2018-07 1 site
    Other conditions: Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    View official trial listing →
  • Completed NCT NCT02730377

    Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 1991 participants Est. completion 2019-08-12 232 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT02763007

    An Extension Study of PEAK Trial

    Not yet reported Kun-Ho Yoon 41 participants Est. completion 2019-02-28 1 site
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT02767063

    Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)

    Not yet reported, Not yet reported Versailles Hospital 100 participants Est. completion 2028-06 23 sites
    Other conditions: Leukemia, Myeloid, Chronic-Phase
    View official trial listing →
  • Completed NCT NCT02774343

    PPARγ Agonist Treatment for Cocaine Dependence

    Not yet reported, Not yet reported The University of Texas Health Science Center, Houston 30 participants Est. completion 2015-06 1 site
    Alcohol use disorder Other conditions: Cocaine Use Disorder
    View official trial listing →
  • Completed NCT NCT02787551

    Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

    Not yet reported Sanofi 514 participants Est. completion 2018-11-17 124 sites Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02852083

    A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC

    Not yet reported University Hospital Regensburg 86 participants Est. completion 2020-07 9 sites
    Other conditions: Squamous Cell Lung Cancer, Non-Squamous Cell Lung Cancer, Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT02875821

    Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone

    Not yet reported Yonsei University 44 participants Est. completion 2017-06-07 1 site
    MASLDType 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02887625

    Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

    Not yet reported Dr. Muhammad Abdulghani 410 participants Est. completion 2017-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02919176

    Brown Fat Activation Study

    Not yet reported Philip Kern 39 participants Est. completion 2019-02-04 1 site
    Metabolic syndrome Other conditions: Obese
    View official trial listing →
  • Terminated NCT NCT02942758

    Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML

    Not yet reported University Hospital Regensburg 10 participants Est. completion 2020-03-25 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02954692

    A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey

    Not yet reported Sanofi 112 participants Est. completion 2017-12-22 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02958956

    Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

    Takeda 236507 participants Est. completion 2015-05-29
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT02989649

    Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

    Takeda 593 participants Est. completion 2018-01-26 11 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03011775

    Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease

    Not yet reported Ukrainian Medical Stomatological Academy 43 participants Est. completion 2015-09 1 site
    Other conditions: Adverse Effect, Atherosclerosis, Coronary, Insulin Resistance Syndrome
    View official trial listing →
  • Terminated NCT NCT03060772

    A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study)

    Not yet reported Emory University 50 participants Est. completion 2020-01-28 1 site
    Other conditions: Alcoholism
    View official trial listing →
  • Terminated NCT NCT03080480

    Pioglitazone Therapy for Chronic Granulomatous Disease

    Not yet reported, Not yet reported Children's Hospital of Fudan University 3 participants Est. completion 2019-10-20 1 site
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Completed NCT NCT03125694

    Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea

    Not yet reported Tehran University of Medical Sciences 250 participants Est. completion 2017-04-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03196362

    Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes

    Not yet reported Sun Yat-sen University 50 participants Est. completion 2018-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03231033

    Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis

    Not yet reported Children's Hospital Medical Center, Cincinnati 3 participants Est. completion 2019-04-02 1 site
    Other conditions: Autoimmune Pulmonary Alveolar Proteinosis
    View official trial listing →
  • Completed NCT NCT03298464

    Study of NGM313 in Obese Participants

    Not yet reported NGM Biopharmaceuticals, Inc 25 participants Est. completion 2018-07-17 1 site
    Other conditions: Obese
    View official trial listing →
  • Status unknown NCT NCT03309319

    A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas

    Not yet reported Zhaoyun Zhang 24 participants Est. completion 2018-12-31 1 site
    Other conditions: Pituitary Tumor
    View official trial listing →
  • Status unknown NCT NCT03430284

    Multifactorial Intervention on Diabetes (MIDiab Study)

    Not yet reported Shandong Provincial Hospital 6300 participants Est. completion 2022-12-31 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03440034

    Study of Pioglitazone in Sporadic Inclusion Body Myositis

    Not yet reported Johns Hopkins University 19 participants Est. completion 2020-12-31 1 site
    Other conditions: Myositis, Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Disease, Neuromuscular Diseases, Nervous System Diseases
    View official trial listing →
  • Withdrawn NCT NCT03452267

    Insulin Signaling in Skeletal Muscle

    Not yet reported, Not yet reported Wayne State University Est. completion 2025-06
    Other conditions: Insulin Sensitivity
    View official trial listing →
  • Completed NCT NCT03457597

    Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s

    Not yet reported Corcept Therapeutics 27 participants Est. completion 2018-04-28 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT03471117

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

    Not yet reported The University of Texas at Arlington 5 participants Est. completion 2020-01-14 2 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT03486964

    Use of Incretins in Diabetic Patients

    University of Pavia 2234 participants Est. completion 2021-05-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03499704

    A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy

    Not yet reported Celltrion Pharm, Inc. 133 participants Est. completion 2024-01-16 15 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03501277

    A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants

    Not yet reported Takeda 72 participants Est. completion 2018-07-11 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03646292

    Antidiabetic Drugs for Steatotic Liver Disease

    Not yet reported Yonsei University 51 participants Est. completion 2022-06-16 1 site
    MASLDType 2 diabetes Other conditions: Digestive System Disease, Liver Diseases, Fatty Liver, Non-Alcoholic Fatty Liver Disease, Hypoglycemic Agents, Physiological Effects of Drugs, Sodium-Glucose Cotransporter 2 Inhibitors, Pioglitazone, Molecular Mechanisms of Pharmacological Action, Empagliflozin, Thiazolidinediones
    View official trial listing →
  • Status unknown NCT NCT03757923

    Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism

    Not yet reported, Not yet reported Dow University of Health Sciences 110 participants Est. completion 2019-01 1 site
    Other conditions: Menstrual Irregularities, Hyperandrogenism
    View official trial listing →
  • Status unknown NCT NCT03794518

    Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF

    Not yet reported Hamad Medical Corporation 648 participants Est. completion 2021-12 1 site
    Other conditions: Risk Reduction
    View official trial listing →
  • Terminated NCT NCT03860753

    Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (Pilot)

    Not yet reported, Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2019-08-23 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT03871621

    Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial

    Not yet reported Mackay Memorial Hospital 76 participants Est. completion 2022-08-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT03878459

    Dapagliflozin Plus Pioglitazone in T1DM

    Not yet reported The University of Texas Health Science Center at San Antonio 120 participants Est. completion 2027-12-31 3 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03910361

    Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

    Not yet reported Dong-A ST Co., Ltd. 51 participants Est. completion 2020-07-02 7 sites
    Type 2 diabetes Other conditions: Non-Alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT03917225

    A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients

    Not yet reported Minoryx Therapeutics, S.L. 39 participants Est. completion 2020-09-14 5 sites Stand-alone
    Other conditions: Friedreich Ataxia
    View official trial listing →
  • Status unknown NCT NCT03950505

    To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes

    Not yet reported Yonsei University 60 participants Est. completion 2020-12 1 site
    Type 2 diabetes Other conditions: Non-alcoholic Steatohepatitis
    View official trial listing →
  • Completed NCT NCT04017221

    Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes

    Canadian Network for Observational Drug Effect Studies, CNODES 1249636 participants Est. completion 2019-12-01 1 site
    Type 2 diabetes Other conditions: Urosepsis, Diabetic Ketoacidosis, Lower Extremity Amputation
    View official trial listing →
  • Completed NCT NCT04148183

    Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.

    Not yet reported, Not yet reported J JESUS VENEGAS, MD 30 participants Est. completion 2009-01-01
    Other conditions: Insulin Resistance
    View official trial listing →
  • Status unknown NCT NCT04287387

    Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents

    Not yet reported Peking Union Medical College Hospital 180 participants Est. completion 2021-03-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04300127

    Pioglitazone for Idiopathic Gastroparesis

    Not yet reported Johns Hopkins University 14 participants Est. completion 2025-03-18 1 site
    Other conditions: Gastroparesis
    View official trial listing →
  • Status unknown NCT NCT04334005

    Vitamin D on Prevention and Treatment of COVID-19

    Not yet reported Universidad de Granada 200 participants Est. completion 2020-06-30 2 sites
    Other conditions: Patients Infected With COVID-19
    View official trial listing →
  • Completed NCT NCT04370093

    Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss

    Not yet reported University of Texas Southwestern Medical Center 29 participants Est. completion 2025-05-28 1 site
    Other conditions: Nephrolithiasis, Uric Acid
    View official trial listing →
  • Status unknown NCT NCT04392557

    Anti-inflammatory Status in DM2 Treated Patients

    Not yet reported University of Catanzaro 36 participants Est. completion 2021-06-20 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT04416269

    Oral Anti Diabetic Agents in the Hospital

    Not yet reported Emory University 85 participants Est. completion 2025-04-11 3 sites Added to GLP-1
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04473274

    GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study

    Not yet reported Samaritan Health Services 10 participants Est. completion 2020-12-01 1 site
    Other conditions: Coronavirus Infection, Diabetes
    View official trial listing →
  • Completed NCT NCT04535700

    Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19

    Not yet reported Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 8 participants Est. completion 2022-01-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04626323

    Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease

    Not yet reported Hospital Alemão Oswaldo Cruz 60 participants Est. completion 2024-12 1 site
    Type 2 diabetes Other conditions: Kidney Disease, Chronic, Kidney Injury
    View official trial listing →
  • Withdrawn NCT NCT04658849

    Insulin Resistance Following ADT for Prostate CA

    Not yet reported St. Louis University Est. completion 2023-03-29 1 site
    Other conditions: Insulin Resistance, Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT04662866

    Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose

    Not yet reported Oslo University Hospital 64 participants Est. completion 2023-10 1 site
    Prediabetes Other conditions: Insulin Sensitivity, Glucose Metabolism Disorders
    View official trial listing →
  • Completed NCT NCT04843046

    Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention

    Not yet reported The University of Texas Health Science Center, Houston 61 participants Est. completion 2025-10-15 1 site
    Other conditions: Cocaine Use Disorder
    View official trial listing →
  • Completed NCT NCT04867252

    Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome

    Not yet reported Khyber Medical University Peshawar 88 participants Est. completion 2021-08-03 1 site
    Other conditions: PCOS
    View official trial listing →
  • Completed NCT NCT04883125

    Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

    Not yet reported Mansoura University 90 participants Est. completion 2021-04-15 1 site
    Other conditions: Chronic Myelogenous Leukemia, BCR-ABL Positive, CML, Chronic Phase
    View official trial listing →
  • Completed NCT NCT04885712

    A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

    Not yet reported Boryung Pharmaceutical Co., Ltd 378 participants Est. completion 2023-03-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04976283

    Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver

    Not yet reported Getz Pharma 123 participants Est. completion 2023-11-15 1 site
    Type 2 diabetesMASHMASLD
    View official trial listing →
  • Withdrawn NCT NCT05098327

    Pioglitazone and Insulin Resistance in ADT

    Not yet reported State University of New York at Buffalo Est. completion 2023-03-31 1 site
    Type 2 diabetes Other conditions: Prostate Cancer, Insulin Resistance, Androgen Deficiency
    View official trial listing →
  • Completed NCT NCT05107765

    Effects of Pioglitazone on Stress Reactivity and Alcohol Craving

    Not yet reported, Not yet reported The University of Texas Health Science Center, Houston 67 participants Est. completion 2024-08-16 1 site
    Alcohol use disorder
    View official trial listing →
  • Active, not recruiting NCT NCT05220917

    Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

    Brigham and Women's Hospital 781430 participants Est. completion 2027-09-30 1 site
    Type 2 diabetes Other conditions: Cardiovascular Events, Renal Disease
    View official trial listing →
  • Completed NCT NCT05360147

    Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus

    Not yet reported Third Military Medical University 30 participants Est. completion 2021-05-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05394142

    A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)

    Not yet reported Fundació Sant Joan de Déu 364 participants Est. completion 2025-04 7 sites
    Other conditions: Polycystic Ovary Syndrome (PCOS)
    View official trial listing →
  • Completed NCT NCT05411965

    A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.

    Not yet reported Boryung Pharmaceutical Co., Ltd 48 participants Est. completion 2022-07-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05422092

    Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 80 participants Est. completion 2023-12
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05473806

    Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes

    Not yet reported Seung Up Kim 28 participants Est. completion 2023-02-19 4 sites
    Type 2 diabetes Other conditions: Hepatitis B, Chronic, Fibrosis, Liver
    View official trial listing →
  • Completed NCT NCT05521633

    Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver

    Not yet reported King Edward Medical University 96 participants Est. completion 2022-05-24 1 site
    MASLD
    View official trial listing →
  • Terminated NCT NCT05582707

    Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone

    Not yet reported University of Maryland, Baltimore 1 participants Est. completion 2025-12-25 1 site
    Other conditions: Intracerebral Haemorrhage, Intraventricular
    View official trial listing →
  • Status unknown NCT NCT05605158

    Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis

    Not yet reported Tanta University 56 participants Est. completion 2024-11 1 site
    Other conditions: Non Alcoholic Steatohepatitis
    View official trial listing →
  • Status unknown NCT NCT05629806

    Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes

    Not yet reported Nanjing First Hospital, Nanjing Medical University 50 participants Est. completion 2023-05-31 1 site
    Type 2 diabetes Other conditions: Blood Glucose Fluctuation
    View official trial listing →
  • Terminated NCT NCT05659459

    The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2

    Not yet reported Kinarus AG 17 participants Est. completion 2023-10-01 8 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05775380

    The Role of Pioglitazone in Vascular Transcriptional Remodeling

    Not yet reported University of Campinas, Brazil 20 participants Est. completion 2024-12-22 1 site
    Other conditions: Myocardial Reperfusion Injury
    View official trial listing →
  • Not yet recruiting NCT NCT05875675

    Effects of Pioglitazone in Calcific Aortic Valve Disease

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2028-07-01
    Other conditions: Calcification of Aortic Valve, Aortic Valve Stenosis
    View official trial listing →
  • Active, not recruiting NCT NCT05919147

    The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia

    Not yet reported Pennington Biomedical Research Center 24 participants Est. completion 2026-06-30 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT06107153

    Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control

    Not yet reported University of Basrah 243 participants Est. completion 2024-11-01 1 site
    Other conditions: Type2diabetes
    View official trial listing →
  • Completed NCT NCT06164665

    Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude

    Not yet reported United States Army Research Institute of Environmental Medicine 9 participants Est. completion 2023-07-01 1 site
    Other conditions: High Altitude
    View official trial listing →
  • Status unknown NCT NCT06243536

    The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients

    Not yet reported University Hospital Sestre Milosrdnice 60 participants Est. completion 2024-12-31 1 site
    Type 2 diabetes Other conditions: Overweight, Disordered Eating Behaviors
    View official trial listing →
  • Not yet recruiting NCT NCT06594172

    Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy

    Not yet reported Affiliated Cancer Hospital & Institute of Guangzhou Medical University 67 participants Est. completion 2027-06-30
    Other conditions: Radiation Disease, Cognitive Impairment, Drug Effect
    View official trial listing →
  • Not yet recruiting NCT NCT06922656

    Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?

    Not yet reported Dasman Diabetes Institute 60 participants Est. completion 2027-01-15 3 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT07057479

    Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin

    Not yet reported Eurofarma Laboratorios S.A. Est. completion 2028-02 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT07083232

    The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic Rats

    Not yet reported Al-Azhar University 50 participants Est. completion 2024-11-30 1 site
    Cardiovascular disease Other conditions: Diabetic
    View official trial listing →
  • Not yet recruiting NCT NCT07180745

    Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease

    Not yet reported Badr University 400 participants Est. completion 2026-03-01 1 site
    MASLDMASH
    View official trial listing →
  • Not yet recruiting NCT NCT07391267

    Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.

    Not yet reported Institute of Liver and Biliary Sciences, India 90 participants Est. completion 2028-12-31 1 site Added to GLP-1
    Chronic kidney disease Other conditions: MAFLD
    View official trial listing →
  • Completed NCT NCT07444424

    A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants

    Not yet reported AstraZeneca 32 participants Est. completion 2026-07-02 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT07472179

    Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS

    Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2026-02-20 1 site
    Other conditions: PCOS(Insulin Resistant)
    View official trial listing →
  • Active, not recruiting NCT NCT07604779

    Enhancing PCOS Management for Better Outcomes of Intracytoplasmic Sperm Injection

    Not yet reported Beni-Suef University 150 participants Est. completion 2027-03-03 1 site
    Other conditions: Polycystic Ovarian Syndrome (PCOS)
    View official trial listing →
  • Not yet recruiting NCT NCT07848191

    Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 Fibrosis

    Not yet reported Madrigal Pharmaceuticals, Inc. 150 participants Est. completion 2027-11
    MASH
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.